Kudos to the Congress of Neuorological Surgeons (CNS) for having the vision to organize its first-ever Innovation and Technology Symposium and to Medtronic for playing a key role in its launch.
Why is this event a big deal? Because this first-of-its-kind gathering for CNS, neurosurgeons, lead engineers, researchers and CEOs will gather in one place to discuss breakthrough technologies and devices in cerebrovascular/endovascular, spine and brain tumor procedures.
The event will take place Oct. 19-23 during the Innovation and Technology Symposium at the Moscone West Convention Center in San Francisco when thought leaders in device technology, imaging, biomaterials, molecular diagnostics and regenerative medicine will present new research and ideas that are moving the neurosurgery field forward.
“Some of these technologies have never been seen before,” says CNS Course Director Brian L. Hoh, MD. “Much of the innovation we will see and discuss at this session could have a dramatic impact on the way neurosurgery and related procedures are performed in the future.”
Ashwini D. Sharan, MD, CNS Annual Meeting Scientific Program Chairman, said, “Neuromedicine is among the most rapidly growing areas in surgery and medicine. This unique and revealing forum will allow neurosurgeons and technologists to identify the gaps between neurosurgeons’ current needs and the technologies and devices being designed and offered today. It is crucial for industry to reduce the lag time between innovative R&D and medical device production and introduction to the marketplace.”
This new symposium is being presented in part through a partnership with Medtronic.
In addition to presenting during the symposium, leaders from Medtronic’s R&D team will offer a glimpse into the future with a lunchtime talk titled, “Emerging Translational Tools for the Exploration of Neurological Disease.” Corporate researchers from other major medical device manufacturers will also be among the presenters, sharing technologies they have in the R&D pipeline and allowing neurosurgeons to provide insightful feedback about the needs they encounter today in the operating suite.
“We recognize the importance of strong collaborative relationships with the neurosurgery community as we strive to find solutions for our customers around the world,” says David Simon, senior director of research and technology at Medtronic ST Neurosurgery. “It is through innovation in technology that we will achieve our goal of helping our customers improve patient care. We are eager to support the CNS in its endeavor to bring such innovation into the spotlight, and we look forward to providing a peek into our vision of the future.”
Ali R. Rezai, CNS president, adds, “Continued collaboration between medical professionals and industry ensures that our focus as physicians remains on the best possible patient outcomes. This symposium is an essential step towards changing the way medical care is delivered in the United States and, ultimately, throughout the world.”
Any event that brings surgeons and device makers together to collaborate not only deserves kudos, it deserves to be duplicated throughout all key medtech market segments. Additional details and registration information are available at the CNS Annual Meeting site.